To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Scleroderma Foundation


300 Rosewood Drive, Suite 105
Danvers, MA 1923 USA





800 Number


Email Address


The Scleroderma Foundation (SF) is a non-profit, 501(c)3 organization dedicated to serving those affected by scleroderma. Its mission is three-fold: to help patients and their families cope with scleroderma by offering support groups, physician referrals, and educational information; to promote public awareness and education through patient and health professional seminars, informational brochures and publicity campaigns; to stimulate and support research to improve treatment options for patients and to ultimately find the cause of and cure for scleroderma and related disorders. Scleroderma is a rare connective tissue disorder characterized by abnormal thickening of the skin.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.